|
OSBPL10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
1.759110E-03 |
| Normal-vs-Stage3 |
9.92600446281244E-11 |
| Normal-vs-Stage4 |
1.11099999977604E-07 |
| Stage1-vs-Stage2 |
1.345830E-01 |
| Stage1-vs-Stage3 |
8.178000E-01 |
| Stage1-vs-Stage4 |
7.058200E-01 |
| Stage2-vs-Stage3 |
1.777160E-01 |
| Stage2-vs-Stage4 |
1.067390E-01 |
| Stage3-vs-Stage4 |
5.755600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
9.832500E-04 |
| Normal-vs-Asian |
3.54719999999809E-05 |
| Caucasian-vs-AfricanAmerican |
1.993010E-01 |
| Caucasian-vs-Asian |
6.599000E-01 |
| AfricanAmerican-vs-Asian |
1.672040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.39810426861231E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
6.822200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.10382880192628E-15 |
| Normal-vs-Age(41-60Yrs) |
4.21662704752634E-12 |
| Normal-vs-Age(61-80Yrs) |
9.95140000403794E-08 |
| Normal-vs-Age(81-100Yrs) |
1.556749999998E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.181610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.201700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.530200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.557600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.417600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.365800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.701800E-01 |
| Classical-VS-Follicular |
5.78639999999631E-05 |
| Classical-VS-Other |
8.765800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.242500E-02 |
| Tall-VS-Other |
8.401800E-01 |
| Tall-VS-Normal |
2.06250000001074E-06 |
| Follicular-VS-Other |
3.442400E-01 |
| Follicular-VS-Normal |
3.605000E-03 |
| Other-VS-Normal |
1.403830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.58577661691606E-12 |
| Normal-vs-N1 |
2.26979999999877E-05 |
| N0-vs-N1 |
8.996200E-01 |
|
|
